「no」の検索結果
164件：36～40件目を表示
-
Publications | Research & Development | SENJU Pharmaceutica
Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuki Wada2, Kazunori Omatsu2, on behalf of the SJP-0132 clinical study investigators 1: Department of Ophthalmology,...
http://www.senju.co.jp/english/rd/thesis/ -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
suring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeP3（China） SJP-0008Central Reti...
http://www.senju.co.jp/english/rd/pipeline.html -
千寿製薬について | 千寿製薬株式会社
CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Production system Quality policy
http://www.senju.co.jp/english/about/ -
发表论文 | 研究与开发 | 千寿制药株式会社
Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuki Wada2, Kazunori Omatsu2, on behalf of the SJP-0132 clinical study investigators 1: Department of Ophthalmology,...
https://www.senju.co.jp/chinese/rd/thesis/ -
千寿製薬株式会社
5 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
http://www.senju.co.jp/english/